MedTrace Logo

Providing Rapid Out of Hospital Acute Cardiovascular Treatment (PROACT)

NCT01634425 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 601

Last updated 2015-10-20

No results posted yet for this study

Summary

The purpose of this study is to determine if early diagnosis and risk stratification acquired through pre-hospital clinical assessment, 12-lead electrocardiogram and point of care biomarkers will facilitate enhanced triage and treatment in patients with presumed non-ST elevation acute coronary syndromes (NSTEMI).

Conditions

  • NSTEMI

Interventions

DEVICE

Alere Triage Meter Pro

Troponin and BNP measured on point of care meter.

Sponsors & Collaborators

  • Canadian VIGOUR Centre

    collaborator OTHER

  • University of Alberta

    lead OTHER

Principal Investigators

  • Paul Armstrong, MD · Canadian VIGOUR Centre

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
31 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01634425 on ClinicalTrials.gov